Depressive disorder
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Then, we analyzed the expression of NET correlation with inflammatory cytokines to provide a new direction for detecting the association mechanism between depression and hypertension.
|
30957546 |
2020 |
Depressive disorder
|
0.400 |
Biomarker
|
disease |
BEFREE |
Melatonin treatment affects changes in adrenal gene expression of catecholamine biosynthesizing enzymes and norepinephrine transporter in the rat model of chronic-stress-induced depression.
|
30773040 |
2019 |
Depressive disorder
|
0.400 |
Biomarker
|
disease |
BEFREE |
The serotonin transporter belongs to the family of sodium-chloride coupled neurotransmitter transporter and is related to depression in humans.
|
31442583 |
2019 |
Depressive disorder
|
0.400 |
Biomarker
|
disease |
BEFREE |
The locus coeruleus (LC), which has high NET concentration, has been attributed to brain networks involved in depression.
|
30238915 |
2018 |
Depressive disorder
|
0.400 |
Biomarker
|
disease |
BEFREE |
The norepinephrine transporter occupancy at week 2 in hypothalamus but not in other regions predicted improvement in depression as reflected by reduction in MADRS scores from baseline to week 7.
|
29016993 |
2018 |
Depressive disorder
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
In addition, we found two genes, SLC6A4 and SLC6A2, to be the main therapeutic targets, and Serotonin-Norepinephrine Reuptake Inhibitors (SNRI) and Tricyclic Antidepressants (TCA) to be the most effective drugs for individuals with depression at risk for suicide.
|
29331709 |
2018 |
Depressive disorder
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Norepinephrine Transporter Gene Variants and Remission From Depression With Venlafaxine Treatment in Older Adults.
|
28068779 |
2017 |
Depressive disorder
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Our study indicates that DNA methylation levels of nine CpG sites in NET gene promoter region are not associated with depression and hypertension.
|
28737436 |
2017 |
Depressive disorder
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Our results suggest that a NET 182C and 5-HTTLPR polymorphism interaction is associated with susceptibility to treatment resistant depression and ECT treatment response in antidepressant resistant depression patients.
|
25650523 |
2015 |
Depressive disorder
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
The NET and 5-HT1A polymorphisms appear to have similar effects on hippocampal volume in patients and controls while the 5-HTTLPR polymorphism differentially affects hippocampal volume in the presence of depression.
|
25990886 |
2015 |
Depressive disorder
|
0.400 |
Biomarker
|
disease |
PSYGENET |
Our results suggest that a NET 182C and 5-HTTLPR polymorphism interaction is associated with susceptibility to treatment resistant depression and ECT treatment response in antidepressant resistant depression patients.
|
25650523 |
2015 |
Depressive disorder
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Although several studies have investigated possible associations between norepinephrine neurotransmitter transporter gene (SLC6A2) polymorphisms and depression, few studies have examined associations between SLC6A2 polymorphisms and suicide.
|
24655776 |
2014 |
Depressive disorder
|
0.400 |
Biomarker
|
disease |
PSYGENET |
Although several studies have investigated possible associations between norepinephrine neurotransmitter transporter gene (SLC6A2) polymorphisms and depression, few studies have examined associations between SLC6A2 polymorphisms and suicide.
|
24655776 |
2014 |
Depressive disorder
|
0.400 |
Biomarker
|
disease |
PSYGENET |
Genetic moderation of child maltreatment effects on depression and internalizing symptoms by serotonin transporter linked polymorphic region (5-HTTLPR), brain-derived neurotrophic factor (BDNF), norepinephrine transporter (NET), and corticotropin releasing hormone receptor 1 (CRHR1) genes in African American children.
|
25422957 |
2014 |
Depressive disorder
|
0.400 |
Biomarker
|
disease |
PSYGENET |
The results from our study do not suggest SLC6A2 as a susceptibility gene for depression in the Danish population.
|
23969988 |
2013 |
Depressive disorder
|
0.400 |
Biomarker
|
disease |
BEFREE |
The results from our study do not suggest SLC6A2 as a susceptibility gene for depression in the Danish population.
|
23969988 |
2013 |
Depressive disorder
|
0.400 |
Biomarker
|
disease |
PSYGENET |
Compared with VM rats, the PM rats showed significant relief of depression-like behaviors, decrease in the malondialdehyde level, increase in superoxide dismutase and catalase activities, and increase in 5-HTT and NET expression.
|
23636256 |
2013 |
Depressive disorder
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
The present findings demonstrate that corticosterone up-regulates the expression and function of NET in vitro, indicating the action of corticosterone on the noradrenergic phenotype may play an important role in the correlation between stress and the development of depression.
|
20070865 |
2010 |
Depressive disorder
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Therefore, the neurotransmitter transporter genes, SLC6A3 (dopamine) and SLC6A4 (serotonin) are candidates for depression in PD.
|
18973248 |
2009 |
Depressive disorder
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
In conclusion, our results favor the hypothesis that monoaminergic neurotransmission in general and the F528C NET and R219L 5-HT(1A) receptor variants in particular are involved in the pathogenesis of depression.
|
19105200 |
2009 |
Depressive disorder
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
It was shown that the NET-T182C, interacting with 5-HTTLPR, was associated with the susceptibility to depression.
|
19468717 |
2009 |
Depressive disorder
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
MPT analyses show significant associations of the norepinephrine transporter (NET, SLC6A2) -182 T/C (rs2242446) with recurrent depression [odds ratio, OR = 4.15 (1.91-9.02)], NET -3081 A/T (rs28386840) with increase in appetite [OR = 3.58 (1.53-8.39)] and the presynaptic choline transporter (CHT, SLC5A7) rs1013940" genes_norm="60482">Ile89Val (rs1013940) with HAM-D-17 total score {i.e. overall depression severity [OR = 2.74 (1.05-7.18)]}.
|
18081710 |
2008 |
Depressive disorder
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Since NE signaling contributes to diverse brain functions, we hypothesize that promoter variation within the human NET gene (solute carrier family 6, member 2; SLC6A2) may impact risk for NE-related disorders, including depression, attention deficit hyperactive disorder (ADHD), and autonomic dysfunction.
|
18591486 |
2008 |